256
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Expression of Inflammatory and Regenerative Genes in a Model of Liver Ischemia/Reperfusion and Partial Hepatectomy

, MD, PhD, , MD, PhD, , PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD, FACS show all
Pages 67-73 | Received 03 Mar 2015, Accepted 05 Jun 2015, Published online: 16 Sep 2015

REFERENCES

  • Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–862.
  • Ho CK, Lee CW, Lu J, et al. New hope for an old cure: a pilot animal study on selective venesection in attenuating the systemic effects of ischaemic-reperfusion injury. Ann Acad Med Singapore. 2009;38:569–575.
  • Abu-Amara M, Gurusamy K, Hori S, et al. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB. 2010;12:4–14.
  • Arkadopoulos N, Defterevos G, Nastos C, et al. Development of a porcine model of post-hepatectomy liver failure. J Surg Res. 2011;170:e233–242.
  • Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor-a in liver ischemia/reperfusion injury. J Invest Surg. 2011;24:178–188.
  • Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22:46–55.
  • Feindel CM, Harper R, Wallace AC, et al. Tolerance of the liver to ischemia: an experimental study. Can J Surg. 1981;24:147–149.
  • Prieto-Moure B, Carabén-Redaño A, Aliena-Valero A, et al. Allopurinol in renal ischemia. J Invest Surg. 2014;27:304–316.
  • Jalan R, O Damink SW, Deutz NE, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999;354:1164–1168.
  • van de Kerkhove MP, Hoekstra R, et al. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials. 2004;25:1613–1625.
  • Suzuki S, Nakamura S, Sakaguchi T, et al. Pathophysiological appraisal of a rat model of total hepatic ischemia with an extracorporeal portosystemic shunt. J Surg Res. 1998;80:22–27.
  • Unno N, Uchiyama T, Yamamoto N, et al. Portal triad occlusion induces endotoxin tolerance: role of portal congestion. J Surg Res. 2006;135:213–217.
  • Hochleitner B, Hengster P, Bucher H, et al. Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver. Artif Organs. 2006;30:906–914.
  • Wang H, Ohkohchi N, Enomoto Y, et al. Effect of portocaval shunt on residual extreme small liver after extended hepatectomy in porcine. World J Surg. 2006;30:2014–2022.
  • Ytrebø LM, Nedredal GI, Langbakk B, et al. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure. Scand J Gastroenterol. 2002;37:1077–1088.
  • Ochiai H, Nakamura S, Suzuki S, et al. Pancreatic damage resulting from temporary portal triad interruption during partial hepatectomy: protective effect of a prostaglandin I2 analogue. J Surg Res. 1997;73:129–136.
  • Garcia-Pagán JC, Zhang JX, Sonin N, et al. Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1. Shock. 1999;11:325–329.
  • Marubashi S, Sakon M, Nagano H, et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery. 2004;136:1028–1037.
  • Abu-Amara M, Yang SY, Tapuria N, et al. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl. 2010;16:1016–1032.
  • Fausto N. Liver regeneration. J Hepatol. 2000;32:19–31.
  • Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration. J Am Coll Surg. 2003;197:634-659.
  • Teoh N, Field J, Farrell G. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice. J Hepatol. 2006;45:20–27.
  • Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–53.
  • Stepniak E, Ricci R, Eferl R, et al. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 2006;20:2306–2314.
  • Li W, Liang X, Kellendonk C, et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem. 2002;277:28411–28417.
  • Behrens A, Sibilia M, David JP, et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO. J 2002;21:1782–1790.
  • Hafez T, Moussa M, Nesim I, et al. The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res. 2007;138:88–99.
  • Peralta C, Fernández L, Panés J, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology. 2001;33:100–113.
  • Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290:583–589.
  • Rajesh M, Pan H, Mukhopadhyay P, et al. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol. 2007;82:1382–1389.
  • Scotté M, Masson S, Lyoumi S, et al. Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine. 1997;9:859–867.
  • Hallbeck AL, Walz TM, Wasteson A. Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells. Biosci Rep. 2001;21:325–339.
  • Tomiya T, Ogata I, Fujiwara K. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol. 1998;153: 955–961.
  • Mitchell C, Nivison M, Jackson LF, et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem. 2005;280:2562–2568.
  • Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 1995;9:1527–1536.
  • Sowa JP, Best J, Benko T, et al. Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World J Gastroenterol. 2008;14:7093–7100.
  • Lowes KN, Croager EJ, Olynyk JK, et al. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol. 2003;18:4–12.
  • Mangnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver Int. 2003;23:124–138.
  • Caban A, Oczkowicz G, Abdel-Samad O, et al. Influence of Kupffer cells on the early phase of liver reperfusion. Transplant Proc. 2002;34:694–697.
  • Llacuna L, Mari M, Lluis JM, et al. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol. 2009;174:1776–1785.
  • Hsu CM, Wang JS, Liu CH, et al. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock. 2002;17:280–285.
  • Hamada T, Duarte S, Tsuchihashi S, et al. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am J Pathol. 2009;174:2265–2277.
  • Wang LM, Tian XF, Song QY, et al. Expression and role of inducible nitric oxide synthase in ischemia–reperfusion liver in rats. Hepatobiliary Pancreat Dis Int. 2003;2: 252–258.
  • Newsome PN, Plevris JN, Nelson LJ, et al. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl. 2000;6:21–31.
  • Filipponi F, Fabbri LP, Marsili M, et al. A new surgical model of acute liver failure in the pig: experimental procedure and analysis of liver injury. Eur Surg Res. 1991;23:58–64.
  • Gao Y, Mu N, Xu XP, et al. Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system. World J Gastroenterol. 2005;11:5468–5474.
  • Ladurner R, Hochleitner B, Schneeberger S, et al. Extended liver resection and hepatic ischemia in pigs: a new, potentially reversible model to induce acute liver failure and study artificial liver support systems. Eur Surg Res. 2005;37:365–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.